[Pharmacokinetics of hopantenic acid upon peroral administration]. 2010

M V Karlina, and O N Pozharitskaia, and V M Kosman, and A N Shikov, and M A Lazukina, and G I D'iachuk

A simple, specific and sensitive RP-HPLC method with UV detection for the determination of hopantenic acid in human blood plasma has been developed. The pharmacokinetics of drug pantocalcin upon single peroral administration was investigated on 18 healthy volunteers. The peak of hopantenic acid in blood plasma was achieved at 1.56 h and the elimination half life was 6.68 h. No hopantenic acid in blood plasma is found in 48 h.

UI MeSH Term Description Entries
D008297 Male Males
D010205 Pantothenic Acid A butyryl-beta-alanine that can also be viewed as pantoic acid complexed with BETA ALANINE. It is incorporated into COENZYME A and protects cells against peroxidative damage by increasing the level of GLUTATHIONE. Vitamin B 5,Calcium Pantothenate,Dexol,Vitamin B5,Zinc Pantothenate,B 5, Vitamin,B5, Vitamin,Pantothenate, Calcium,Pantothenate, Zinc
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005260 Female Females
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D018697 Nootropic Agents Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. Anti-Dementia Agent,Antidementia Agent,Cognitive Enhancer,Cognitive Enhancers,Nootropic,Nootropic Agent,Nootropic Drug,Procognitive Agent,Anti-Dementia Agents,Antidementia Agents,Nootropic Drugs,Nootropics,Procognitive Agents,Agent, Anti-Dementia,Agent, Antidementia,Agent, Nootropic,Agent, Procognitive,Agents, Anti-Dementia,Agents, Antidementia,Agents, Nootropic,Agents, Procognitive,Anti Dementia Agent,Anti Dementia Agents,Drug, Nootropic,Drugs, Nootropic,Enhancer, Cognitive,Enhancers, Cognitive

Related Publications

M V Karlina, and O N Pozharitskaia, and V M Kosman, and A N Shikov, and M A Lazukina, and G I D'iachuk
December 1974, Antibiotiki,
M V Karlina, and O N Pozharitskaia, and V M Kosman, and A N Shikov, and M A Lazukina, and G I D'iachuk
December 1977, European journal of clinical pharmacology,
M V Karlina, and O N Pozharitskaia, and V M Kosman, and A N Shikov, and M A Lazukina, and G I D'iachuk
January 2010, Eksperimental'naia i klinicheskaia farmakologiia,
M V Karlina, and O N Pozharitskaia, and V M Kosman, and A N Shikov, and M A Lazukina, and G I D'iachuk
January 2009, Eksperimental'naia i klinicheskaia farmakologiia,
M V Karlina, and O N Pozharitskaia, and V M Kosman, and A N Shikov, and M A Lazukina, and G I D'iachuk
December 2005, Bulletin of experimental biology and medicine,
M V Karlina, and O N Pozharitskaia, and V M Kosman, and A N Shikov, and M A Lazukina, and G I D'iachuk
July 1949, Journal of the American Medical Association,
M V Karlina, and O N Pozharitskaia, and V M Kosman, and A N Shikov, and M A Lazukina, and G I D'iachuk
January 2014, Eksperimental'naia i klinicheskaia farmakologiia,
M V Karlina, and O N Pozharitskaia, and V M Kosman, and A N Shikov, and M A Lazukina, and G I D'iachuk
January 2004, Eksperimental'naia i klinicheskaia farmakologiia,
M V Karlina, and O N Pozharitskaia, and V M Kosman, and A N Shikov, and M A Lazukina, and G I D'iachuk
January 1950, Deutsches Archiv fur klinische Medizin,
M V Karlina, and O N Pozharitskaia, and V M Kosman, and A N Shikov, and M A Lazukina, and G I D'iachuk
December 1987, Methods and findings in experimental and clinical pharmacology,
Copied contents to your clipboard!